Surgical Pain Control With Ropivacaine by Atomized Delivery

• Status: Completed
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this trial is to determine the effect of spraying a local anesthetic called Ropivacaine (numbing medicine) into the abdominal cavity prior to surgery. Ropivacaine is a local anesthetic used to block pain in the body. There are studies showing that Ropivacaine decreases the pain of surgery with minimally invasive (laparoscopic) appendix and gallbladder removal but has not been tried in robotic pelvic surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Loyola University
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• Consent to undergo robotic assisted gynecologic or urologic surgery

• Between the ages of 18 and 75

• Able to consent, fill out study documents, and complete all study procedures and follow-up visits

Exclusion Criteria:

• Patients with an allergy to local anesthetics

• Patients with severe underlying cardiovascular, renal or hepatic disease

• Pregnant patients